Association of white blood cell count and peripheral arterial disease in patients with and without traditional risk factors

Angiology

Volumn 61, Issue 4, 2010, Pages 382-387

  Chen, Jien Jiun ^a   Lin, Lian Yu ^a   Lee, Hsiu Hao ^b   Lai, Lin Ping ^a   Lin, Jiunn Lee ^a   Huang, Juey Jen ^a   Tseng, Chuen Den ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

Chronic kidney disease; Diabetes; Hypercholesterolemia; Inflammation; Peripheral artery disease; White blood cell count

Indexed keywords

AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SMOKING;

AGED; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NUTRITION SURVEYS; PERIPHERAL VASCULAR DISEASES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SMOKING; UNITED STATES;

EID: 77952738481     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319709344575     Document Type: Article

References (33)

1. Creager MA Medical management of peripheral arterial disease. Cardiol Rev. 2001; 9 (4). 238-245.
2. O'Hare AM, Glidden DV, Fox CS, Hsu CY High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the national health and nutrition examination survey 1999-2000. Circulation. 2004; 109 (3). 320-323.
3. Selvin E., Erlinger TP Prevalence of and risk factors for peripheral arterial disease in the United States: results from the national health and nutrition examination survey, 1999-2000. Circulation. 2004; 110 (6). 738-743.
4. Kannel WB, Anderson K., Wilson PW White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA. 1992; 267 (9). 1253-1256.
5. Grau AJ, Buggle F., Becher H., Werle E., Hacke W. The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res. 1996; 82 (3). 245-255.
6. Wildman RP, Muntner P., Chen J., Sutton-Tyrrell K., He J. Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002. Am J Cardiol. 2005; 96 (11). 1579-1583.
7. Newman AB, Siscovick DS, Manolio TA, et al. Ankle-arm index as a marker of atherosclerosis in the cardiovascular health study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation. 1993; 88 (3). 837-845.
8. Tong PC, Lee KF, So WY, et al. White blood cell count is associated with macro-and microvascular complications in chinese patients with type 2 diabetes. Diabetes Care. 2004; 27 (1). 216-222.
9. Niazi K., Khan TH, Easley KA Diagnostic utility of the two methods of ankle brachial index in the detection of peripheral arterial disease of lower extremities. Catheter Cardiovasc Interv. 2006; 68 (5). 788-792.
10. Ford ES, Ajani UA, Mokdad AH The metabolic syndrome and concentrations of C-reactive protein among U. S. youth. Diabetes Care. 2005; 28 (4). 878-881.
11. Levey AS, Coresh J., Greene T., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145 (4). 247-254.
12. Omenn GS, Beresford SA, Motulsky AG Preventing coronary heart disease: B vitamins and homocysteine. Circulation. 1998; 97 (5). 421-424.
13. Perlstein TS, Pande RL, Beckman JA, Creager MA Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: national health and nutrition examination survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol. 2008; 28 (1). 166-172.
14. Asfar S., Safar HA Homocysteine levels and peripheral arterial occlusive disease: a prospective cohort study and review of the literature. J Cardiovasc Surg (Torino). 2007; 48 (5). 601-605.
15. Brown DW, Giles WH, Croft JB White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol. 2001; 54 (3). 316-322.
16. Salonen R., Salonen JT Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis. 1990; 81 (1). 33-40.
17. Elkind MS, Cheng J., Boden-Albala B., Paik MC, Sacco RL Elevated white blood cell count and carotid plaque thickness: the northern Manhattan stroke study. Stroke. 2001; 32 (4). 842-849.
18. Brown DW, Ford ES, Giles WH, Croft JB, Balluz LS, Mokdad AH. Associations between white blood cell count and risk for cerebrovascular disease mortality: NHANES II mortality study, 1976-1992. Ann Epidemiol. 2004; 14 (6). 425-430.
19. Nakanishi N., Yoshida H., Matsuo Y., Suzuki K., Tatara K. White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men. Diabetologia. 2002; 45 (1). 42-48.
20. Shankar A., Klein BE, Klein R. Relationship between white blood cell count and incident hypertension. Am J Hypertens. 2004; 17 (3). 233-239.
21. Nakanishi N., Sato M., Shirai K., Suzuki K., Tatara K. White blood cell count as a risk factor for hypertension: a study of Japanese male office workers. J Hypertens. 2002; 20 (5). 851-857. (Pubitemid 34913664) (Pubitemid 34913664)
22. Tani S., Nagao K., Anazawa T., et al. Association of circulating leukocyte count with coronary atherosclerosis regression after pravastatin treatment. Atherosclerosis. 2008; 198 (2). 360-365.
23. Lee YJ, Lee JW, Kim JK, et al. Elevated white blood cell count is associated with arterial stiffness. Nutr Metab Cardiovasc Dis. 2009; 19 (1). 3-7.
24. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G., Wouters EF Systemic effects of smoking. Chest. 2007; 131 (5). 1557-1566.
25. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999; 340 (2). 115-126.
26. Libby P., Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105 (9). 1135-1143.
27. Fan J., Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb. 2003; 10 (2). 63-71.
28. Husmann M., Dorffler-Melly J., Kalka C., Diehm N., Baumgartner I., Silvestro A. Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease. J Vasc Surg. 2008; 48 (5). 1211-1216.
29. Silvestro A., Scopacasa F., Ruocco A., et al. Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease. Vasc Med. 2003; 8 (4). 225-232.
30. Loffredo L., Marcoccia A., Pignatelli P., et al. Oxidative-stress- mediated arterial dysfunction in patients with peripheral arterial disease. Eur Heart J. 2007; 28 (5). 608-612. (Pubitemid 47355519) (Pubitemid 47355519)
31. Nasir K., Guallar E., Navas-Acien A., Criqui MH, Lima JA Relationship of monocyte count and peripheral arterial disease: results from the national health and nutrition examination survey 1999-2002. Arterioscler Thromb Vasc Biol. 2005; 25 (9). 1966-1971.
32. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995; 91 (11). 2844-2850.
33. Belge KU, Dayyani F., Horelt A., et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol. 2002; 168 (7). 3536-3542.